Meta-analysis of FOLFIRINOX-based neoadjuvant therapy for locally advanced pancreatic cancer

Currently, the combination of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) is the standard therapy for metastatic pancreatic cancer. In recent years, FOLFIRINOX-based neoadjuvant therapy for locally advanced pancreatic cancer (LAPC) has been gaining an increasing amount of at...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhiliang, Lv, Yongshuang, Li, He, Diao, Rui, Zhou, Jian, Yu, Tianwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837836/
https://www.ncbi.nlm.nih.gov/pubmed/33546009
http://dx.doi.org/10.1097/MD.0000000000024068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837836/
https://www.ncbi.nlm.nih.gov/pubmed/33546009
http://dx.doi.org/10.1097/MD.0000000000024068

Ejemplares similares